Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
In finance, blockchain can streamline settlements and reduce fraud. This intro covers the financial implications using simple terms.
22,998 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
Eric Trump’s American Bitcoin announced a 1-for-15 reverse stock split to protect its Nasdaq listing as its treasury ...
A new leadership style at the Fed could change how markets price future rate moves. This article breaks down the pote...
Inflation data and hawkish Fed messaging dominate markets this week as investors weigh mortgage rates and the path of...
A surprise drop in June inflation is pushing investors to question a July rate hike. Analysts say the july rate hike ...
Geopolitical frictions in the Strait of Hormuz push oil prices higher, reshaping risk and opportunity for energy inve...
Two popular 2x silver ETFs tumble in 2026 as volatility and decay erode leverage. AGQ and ZSL illustrate why daily re...
A veteran professional loses footing as AI reshapes his field. Two years later, he weighs claiming Social Security at...
IREN stock fell sharply as investors reprice AI infrastructure bets after a month of steep declines. While the sector...
ASML dominated the latest quarter with strong results and higher guidance. This article breaks down what that could m...
Bitcoin Japan, which holds no BTC, launches a $60 million fundraising round led by EVO Fund to acquire its first bitc...